Principal Financial Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Principal Financial Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-150,733	Closed	-$6.22M	–	2268
2015 Q2	$6.22M	Sell	150,733 -2,447	-2%	-$87.7K	0.01%	1316
2015 Q1	$5.4M	Sell	153,180 -2,748	-2%	-$93K	0.01%	1347
2014 Q4	$5.01M	Buy	155,928 +7,449	+5%	+$215K	0.01%	1377
2014 Q3	$4.17M	Sell	148,479 -1,699	-1%	-$51.7K	0.01%	1429
2014 Q2	$4.54M	Sell	150,178 -11,624	-7%	-$321K	0.01%	1428
2014 Q1	$4.48M	Buy	161,802 +5,693	+4%	+$149K	0.01%	1426
2013 Q4	$3.99M	Buy	156,109 +13,272	+9%	+$409K	0.01%	1469
2013 Q3	$4.27M	Buy	142,837 +5,712	+4%	+$159K	0.01%	1368
2013 Q2	$3.94M	Buy	+137,125	New	+$3.78M	0.01%	1347

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Principal Financial Group's BRLI Position: Q3 2015 in Review

Principal Financial Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 150,733 shares — an estimated $6.22M sold.

Principal Financial Group first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.22M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Principal Financial Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Principal Financial Group sold 150,733 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $6.22M.
Principal Financial Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Principal Financial Group's BIO-REFERENCE LABS INC-NEW- position peaked at $6.22M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Principal Financial Group's 13F filing for Q3 2015, filed 9 Nov 2015.